long intergenic non-protein coding RNA 896Genealiases: []
Q-omics provides the consensus-scored LINC00896 profile across patient tissues and cancer cell-line models. LINC00896 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC00896 is differentially expressed in 11, with the highest sampling consensus in COAD. Additionally, LINC00896 RNA expression shows 14,090 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight KIRC, COAD, and UVM as cancer lineages where LINC00896 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00896 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00896 survival associations across molecular data types. LINC00896 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00896 RNA expression–survival associations across cancer types. High LINC00896 expression shows unfavorable associations in KIRC, KIRP, UVM, LGG, COAD and CESC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC00896 RNA expression.
This table summarizes LINC00896 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00896. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00896 shows lower tumor expression in THCA and higher tumor expression in COAD, KIRC, BLCA, LIHC and LUAD. The COAD box plot shows higher LINC00896 RNA expression in tumor versus normal tissue (log2 FC = +1.092, t-test p < 0.001).
This table shows molecular features associated with LINC00896 in patient tissues and cancer cell lines. In patient samples, LINC00896 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
